Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123745792 | 12374579 | 2 | F | 201604 | 20160620 | 20160517 | 20160718 | EXP | PHHY2016BR044660 | NOVARTIS | 49.13 | YR | F | Y | 44.50000 | KG | 20160718 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123745792 | 12374579 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 1 DF OF 10 MG, QD | 22334 | 1 | DF | TABLET | QD | ||||||
| 123745792 | 12374579 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 123745792 | 12374579 | 3 | C | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, QD | U | 0 | 25 | MG | TABLET | QD | |||||
| 123745792 | 12374579 | 4 | C | PURAN | LEVOTHYROXINE SODIUM | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123745792 | 12374579 | 1 | Breast cancer metastatic |
| 123745792 | 12374579 | 2 | Product used for unknown indication |
| 123745792 | 12374579 | 3 | Breast cancer |
| 123745792 | 12374579 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123745792 | 12374579 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123745792 | 12374579 | Aphonia | |
| 123745792 | 12374579 | Blood glucose increased | |
| 123745792 | 12374579 | Depression | |
| 123745792 | 12374579 | Diabetes mellitus | |
| 123745792 | 12374579 | Dysphonia | |
| 123745792 | 12374579 | Epistaxis | |
| 123745792 | 12374579 | Fatigue | |
| 123745792 | 12374579 | Gastrooesophageal reflux disease | |
| 123745792 | 12374579 | Headache | |
| 123745792 | 12374579 | Insomnia | |
| 123745792 | 12374579 | Malaise | |
| 123745792 | 12374579 | Muscle fatigue | |
| 123745792 | 12374579 | Nodule | |
| 123745792 | 12374579 | Oral candidiasis | |
| 123745792 | 12374579 | Peripheral swelling | |
| 123745792 | 12374579 | Pruritus | |
| 123745792 | 12374579 | Pyrexia | |
| 123745792 | 12374579 | Sensitivity of teeth | |
| 123745792 | 12374579 | Skin discolouration | |
| 123745792 | 12374579 | Stomatitis | |
| 123745792 | 12374579 | Subcutaneous abscess | |
| 123745792 | 12374579 | Underweight | |
| 123745792 | 12374579 | Urinary tract infection | |
| 123745792 | 12374579 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123745792 | 12374579 | 1 | 201511 | 0 |